Sanjiv Sam Gambhir Selected Research

diazobenzenesulfonic acid (DASA)

12/2021	A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma.
1/2020	Human biodistribution and radiation dosimetry of [18F]DASA-23, a PET probe targeting pyruvate kinase M2.
12/2018	The Utility of [18F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography.
10/2017	Development of [18F]DASA-23 for Imaging Tumor Glycolysis Through Noninvasive Measurement of Pyruvate Kinase M2.
10/2015	PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjiv Sam Gambhir Research Topics

Disease

66	Neoplasms (Cancer) 12/2022 - 11/2005
9	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 11/2005
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2012
7	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2003
6	Neoplasm Metastasis (Metastasis) 12/2022 - 04/2003
6	Melanoma (Melanoma, Malignant) 12/2017 - 05/2007
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2015 - 11/2008
4	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2008
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2011 - 03/2004
3	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2012
3	Lymphoma (Lymphomas) 12/2012 - 03/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2022 - 12/2008
2	Atherosclerotic Plaque (Atheroma) 09/2021 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2018
2	Hypoxia (Hypoxemia) 01/2018 - 07/2007
2	Myocardial Infarction 06/2015 - 04/2008
2	Hyperglycemia 05/2011 - 07/2006
2	Squamous Cell Carcinoma of Head and Neck 04/2011 - 04/2010
1	Lymphatic Metastasis 12/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Glioma (Gliomas) 12/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hyperthermia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Bacterial Infections (Bacterial Infection) 10/2017
1	Adenocarcinoma 10/2017

Drug/Important Bio-Agent (IBA)

16	Peptides (Polypeptides)IBA 12/2022 - 11/2005
13	IntegrinsIBA 12/2022 - 11/2005
11	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 03/2004
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2007
7	Cystine (L-Cystine)IBA 12/2022 - 02/2010
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2011
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017 - 12/2008
5	Cystine-Knot MiniproteinsIBA 12/2022 - 03/2009
5	RadiopharmaceuticalsIBA 12/2022 - 04/2003
5	diazobenzenesulfonic acid (DASA)IBA 12/2021 - 10/2015
5	arginyl-glycyl-aspartic acidIBA 11/2015 - 11/2005
5	Pharmaceutical PreparationsIBA 01/2013 - 05/2004
4	Pyruvate KinaseIBA 12/2021 - 10/2015
4	Contrast MediaIBA 01/2021 - 06/2010
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2008
4	aspartic acid glycine arginineIBA 11/2015 - 04/2013
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2015 - 05/2007
4	Molecular Probes (Molecular Probe)IBA 06/2010 - 05/2007
3	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 05/2008
3	Rituximab (Mabthera)FDA Link 08/2015 - 12/2013
3	LuciferasesIBA 01/2013 - 04/2007
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 12/2019
2	Carbon Nanotubes (Carbon Nanotube)IBA 09/2021 - 04/2013
2	LigandsIBA 12/2017 - 04/2013
2	EnzymesIBA 01/2017 - 03/2013
2	Technetium Tc 99m MedronateIBA 12/2015 - 07/2013
2	FluorineIBA 11/2015 - 11/2014
2	Streptozocin (Streptozotocin)FDA Link 06/2015 - 05/2011
2	AcidsIBA 01/2015 - 03/2009
2	64Cu-DOTA-rituximabIBA 01/2015 - 10/2012
2	AntigensIBA 04/2014 - 03/2012
2	Thymidine KinaseIBA 05/2011 - 07/2007
2	PeptidomimeticsIBA 02/2010 - 12/2009
2	CY5.5 cyanine dyeIBA 03/2009 - 05/2006
2	Renilla LuciferasesIBA 01/2008 - 07/2007
2	Type 1 Melanocortin ReceptorIBA 06/2007 - 05/2007
2	alpha-MSHIBA 06/2007 - 05/2007
2	Fluorescent Dyes (Fluorescent Probes)IBA 05/2006 - 11/2005
1	SodiumIBA 03/2022
1	Therapeutic UsesIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 03/2022
1	Chelating AgentsIBA 01/2021
1	GastrinsIBA 01/2021
1	CopperIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Circulating Tumor DNAIBA 12/2020
1	CarbonIBA 01/2020
1	Gallium-68IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	TalinIBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019
1	Peroxiredoxin VIIBA 01/2018
1	olaparibIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	pembrolizumabIBA 12/2017
1	PiperazineIBA 10/2017
1	maltodextrinIBA 10/2017

Therapy/Procedure

28	Therapeutics 03/2022 - 04/2003
4	Precision Medicine 01/2018 - 05/2016
3	Radioimmunotherapy 04/2010 - 03/2008
3	Islets of Langerhans Transplantation 12/2006 - 03/2004
2	Aftercare (After-Treatment) 03/2022 - 09/2008
2	Immunotherapy 01/2020 - 04/2010
2	Drug Therapy (Chemotherapy) 02/2012 - 09/2008
2	Quantum Dots (Quantum Dot) 10/2010 - 09/2008
1	Complementary Therapies (Alternative Medicine) 03/2022
1	Intravenous Injections 09/2021
1	Transplantation 01/2020